Zhong-Hai Zhou

411 citations
19 papers · 354 indexed · h-index 12
Topics
Immune Cell Function and Interaction (6 papers)Immunotherapy and Immune Responses (4 papers)Bioactive Compounds and Antitumor Agents (3 papers)
Partner nations
China

In The Last Decade

Zhong-Hai Zhou

19 papers receiving 349 citations

Peers

Zhong-Hai Zhou
Comparison fields: 5 of 73
  • Molecular Biology 152
  • Immunology 96
  • Oncology 58
  • Toxicology 54
  • Cancer Research 35
Replace Chin-Mu Hsu with:
Chin-Mu Hsu Taiwan
M. V. Gazzola Italy
Chia‐Cheng Su Taiwan
Xue Hu China
Liting Huang China
MyongHak Ri China
Yali Zhang China
Yongzhi Wang China
Sai Balaji Andugulapati India
Dhanir Tailor United States
Zhong-Hai Zhou relative to Chin-Mu Hsu Taiwan Chin-Mu Hsu's profile →
Citations per field
00.5×1.5×1.8×
Chin-Mu Hsu · 1×
Citations per year

Countries citing papers authored by Zhong-Hai Zhou

Since Specialization
Citations

This map shows the geographic impact of Zhong-Hai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong-Hai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong-Hai Zhou more than expected).

Fields of papers citing papers by Zhong-Hai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhong-Hai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong-Hai Zhou. The network helps show where Zhong-Hai Zhou may publish in the future.

Co-authorship network of co-authors of Zhong-Hai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhong-Hai Zhou. A scholar is included among the top collaborators of Zhong-Hai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong-Hai Zhou. Zhong-Hai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 1
2 2
3 20
4 1
5 6
6 29
7 12
8 19
9 24
10 15
11 6
12 77
13 49
14 33
15 11
16 4
17 23
18 10
19
[Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor].
12

About Zhong-Hai Zhou

Zhong-Hai Zhou is a scholar working on Toxicology, Immunology and Pharmacology, having authored 19 papers that have together received 354 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (4 papers) and Bioactive Compounds and Antitumor Agents (3 papers). The work is most often cited by research in Toxicology (54 citations), Immunology (96 citations) and Pharmacology (32 citations). Zhong-Hai Zhou has collaborated with scholars based in China. Frequent co-authors include Fuxing Chen, Junquan Liu, Xiaoting Lv, Yongqiang Chen, Lu Zheng, Xiaoting Lu, Xiaoting Wu, Tao Wang, Ling Chen and Juan Zhang. Their work appears in journals such as Annals of Oncology, Experimental Cell Research and Materials & Design.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026